Artificial Intelligence and Antibiotic Discovery
Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in f...
Guardado en:
Autores principales: | Liliana David, Anca Monica Brata, Cristina Mogosan, Cristina Pop, Zoltan Czako, Lucian Muresan, Abdulrahman Ismaiel, Dinu Iuliu Dumitrascu, Daniel Corneliu Leucuta, Mihaela Fadygas Stanculete, Irina Iaru, Stefan Lucian Popa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0df27f45d4c4adc833456fbf19d14d3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Toward Autonomous Antibiotic Discovery
por: Cesar de la Fuente-Nunez
Publicado: (2019) -
Novel Antimicrobials from Uncultured Bacteria Acting against <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
por: Jeffrey Quigley, et al.
Publicado: (2020) -
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
por: Antonia Molloy, et al.
Publicado: (2021) -
Identification of 4-Amino-Thieno[2,3-<italic toggle="yes">d</italic>]Pyrimidines as QcrB Inhibitors in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content>
por: Gregory A. Harrison, et al.
Publicado: (2019) -
Multiple Mutations in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> MmpL3 Increase Resistance to MmpL3 Inhibitors
por: Matthew B. McNeil, et al.
Publicado: (2020)